Form 8-K Aimmune Therapeutics, For: May 16

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/31/2026

1. INTC
2. AMZN
3. RDDT
4. COIN
5. PINS
6. FSLR
7. SYK
8. GILD
9. SBUX
10. SNDK

Go back to Form 8-K Aimmune Therapeutics, For: May 16

Aimmune Therapeutics (AIMT) Has a Catalyst Filled Second Half - Piper Jaffray

May 17, 2016 9:11 AM EDT

Piper Jaffray Aimmune Therapeutics (NASDAQ: AIMT) analyst, Charles Duncan, believes that investigator and patient interest remains high at PALISADE trial sites and that enrollment is on track to complete in 2H16. The company is currently focused on EU site initiations, as it plans... More

Aimmune Therapeutics (AIMT) Tops Q1 EPS by 3c

May 16, 2016 5:09 PM EDT

Aimmune Therapeutics (NASDAQ: AIMT) reported Q1 EPS of ($0.37), $0.03 better than the analyst estimate of ($0.40).

For earnings history and earnings-related data on Aimmune Therapeutics (AIMT) click here.

... More